Exelixis
EXEL
#1855
Rank
A$15.98 B
Marketcap
A$59.39
Share price
-2.18%
Change (1 day)
10.08%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): A$1.35 Billion

According to Exelixis's latest financial reports the company's current earnings are A$2.28 Billion. In 2024 the company made an earning of A$0.97 Billion, an increase over its 2023 earnings that were of A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.35 B38.81%
2024 A$0.97 B164.69%
2023 A$0.36 B9.89%
2022 A$0.33 B-20.33%
2021 A$0.42 B124.82%
2020 A$0.18 B-67.14%
2019 A$0.57 B-11.94%
2018 A$0.64 B185.09%
2017 A$0.22 B-325.82%
2016 -A$0.11 Billion-58.12%
2015 -A$0.25 Billion-37.61%
2014 -A$0.39 Billion9.75%
2013 -A$0.36 Billion65.96%
2012 -A$0.22 Billion-291.63%
2011 A$0.11 B-195.59%
2010 -A$0.12 Billion-42.17%
2009 -A$0.21 Billion-18.98%
2008 -A$0.25 Billion-6.99%
2007 -A$0.27 Billion46.3%
2006 -A$0.19 Billion33.25%
2005 -A$0.14 Billion-30.92%
2004 -A$0.2 Billion44.29%
2003 -A$0.14 Billion12.86%
2002 -A$0.13 Billion22.79%
2001 -A$98.57 Million60.14%
2000 -A$61.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.52 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.01 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.83 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.06 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$33.15 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.53 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.38 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$46.76 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$41.71 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA